Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$120.62 - $141.12 $6,272 - $7,338
52 Added 55.32%
146 $20,000
Q3 2023

Nov 09, 2023

BUY
$121.86 - $144.92 $2,193 - $2,608
18 Added 23.68%
94 $11,000
Q2 2023

Aug 11, 2023

SELL
$130.56 - $146.84 $3,133 - $3,524
-24 Reduced 24.0%
76 $11,000
Q1 2023

May 11, 2023

SELL
$131.53 - $155.76 $22,623 - $26,790
-172 Reduced 63.24%
100 $14,000
Q4 2022

Feb 10, 2023

BUY
$123.31 - $157.26 $31,937 - $40,730
259 Added 1992.31%
272 $43,000
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $9,132 - $10,582
-75 Reduced 85.23%
13 $2,000
Q2 2022

Aug 05, 2022

SELL
$127.07 - $145.39 $2,668 - $3,053
-21 Reduced 19.27%
88 $12,000
Q1 2022

May 13, 2022

SELL
$129.09 - $164.35 $99,915 - $127,206
-774 Reduced 87.66%
109 $15,000
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $1.44 Million - $1.77 Million
-10,248 Reduced 92.07%
883 $153,000
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $1.47 Million - $1.75 Million
11,059 Added 15359.72%
11,131 $1.62 Million
Q2 2021

Aug 13, 2021

BUY
$126.66 - $141.48 $9,119 - $10,186
72 New
72 $10,000
Q4 2018

Feb 14, 2019

SELL
$79.75 - $108.38 $94,424 - $128,321
-1,184 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$105.42 - $114.99 $121,549 - $132,583
-1,153 Reduced 49.34%
1,184 $128,000
Q2 2018

Aug 14, 2018

SELL
$97.35 - $113.14 $110,492 - $128,413
-1,135 Reduced 32.69%
2,337 $257,000
Q1 2018

May 11, 2018

BUY
$96.42 - $107.88 $73,472 - $82,204
762 Added 28.12%
3,472 $348,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,710
2,710 $301,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.